Thorne HealthTech Executives
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
Thorne HealthTech employs about 544 people. The company is managed by 10 executives with a total tenure of roughly 1270 years, averaging almost 127.0 years of service per executive, having 54.4 employees per reported executive. Analysis of Thorne HealthTech's management performance can provide insight into the firm performance.
Thorne |
Thorne HealthTech Management Team Effectiveness
Thorne HealthTech's management efficiency ratios could be used to measure how well Thorne HealthTech manages its routine affairs as well as how well it operates its assets and liabilities.Thorne HealthTech Workforce Comparison
Thorne HealthTech is rated below average in number of employees category among its peers. The total workforce of Consumer Staples industry is at this time estimated at about 176,847. Thorne HealthTech adds roughly 544 in number of employees claiming only tiny portion of stocks in Consumer Staples industry.
Thorne HealthTech Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Thorne HealthTech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Thorne HealthTech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Thorne HealthTech insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Paul Jacobson over a year ago Bona fide gift to Paul Jacobson of 220377 shares of Thorne HealthTech subject to Section 16 | ||
Paul Jacobson over a year ago Acquisition by Paul Jacobson of 500000 shares of Thorne HealthTech subject to Rule 16b-3 | ||
Paul Jacobson over a year ago Payment of 45338 shares by Paul Jacobson of Thorne HealthTech subject to Rule 16b-3 | ||
Paul Jacobson over a year ago Payment of 52619 shares by Paul Jacobson of Thorne HealthTech subject to Rule 16b-3 |
Thorne HealthTech Notable Stakeholders
A Thorne HealthTech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Thorne HealthTech often face trade-offs trying to please all of them. Thorne HealthTech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Thorne HealthTech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Wilson | VP Relations | Profile | |
| Scott Hurth | Chief Officer | Profile | |
| Paul Jacobson | CEO CoFounder | Profile | |
| William McCamy | President | Profile | |
| Thomas McKenna | COO Director | Profile | |
| Kim Pearson | G Counsel | Profile | |
| Bryan Conley | Chief Officer | Profile | |
| Nathan Price | Chief Onegevity | Profile | |
| Michelle Crow | Chief Officer | Profile | |
| Rob Monteleone | VP Sales | Profile |
About Thorne HealthTech Management Performance
The success or failure of an entity such as Thorne HealthTech often depends on how effective the management is. Thorne HealthTech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Thorne management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Thorne management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Thorne Healthtech operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 496 people.
Thorne HealthTech Workforce Analysis
Traditionally, organizations such as Thorne HealthTech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Thorne HealthTech within its industry.Thorne HealthTech Manpower Efficiency
Return on Thorne HealthTech Manpower
| Revenue Per Employee | 420.5K | |
| Revenue Per Executive | 22.9M | |
| Net Income Per Employee | 27.4K | |
| Net Income Per Executive | 1.5M | |
| Working Capital Per Employee | 141.7K | |
| Working Capital Per Executive | 7.7M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |